#nephjc Jeyakumar from India Joining the party late

Check the insightful #NephJC summary by Jeyakumar Meyyappan

#nephjc Jeyakumar joining from Lucknow , India No COI

#NephSky #MedSky 🩸Blood is thicker than water 🌊 Thankfully we thinned out the 2026 KDIGO Anemia Guidelines for you to peruse. Come discuss what's new. Tuesday 2/24/26 at 9pm EST on Bluesky! Summary by @jeyakumarmeyyappan.bsky.social www.nephjc.com/news/kdigo-anemia

#NephJC Jeyakumar Meyyappan from Lucknow, India . No COI Infections are a concern in kidney transplant patients. Wondering if Flozins are worth even a micro minimal risk . Good topic to be discussed

Here is the VA for the INFINITI study of SGLT2i in transplant patients by @glomerican.bsky.social #NephSky #Flozins #Flozination www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstract

www.nephjc.com/news/... 🎨Beautiful visual abstract by Jeyakumar Meyyappan #NephJC

#nephjc Jeyakumar from Lucknow No COI

🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations? 🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social ⏰ #NephJC chat on Jan 27, 9 pm EST www.nephjc.com/news/2026/1/...

Dr Jeyakumar from Lucknow India No COI Just curious to learn about a drug that can treat two diseases

#nephjc Jeyakumar from India Lurking today. Interesting study to discuss.

#nephjc Jeyakumar from Lucknow , India No COI

Ongoing late posts from @theisn.org #ISNWCN from the high impact trial session - this was a great study design The India ALLIANCE GRACE IgAN trial Lead by Succeena Alexander from CMC Vellore #NephSky 1/

First things first — where the story starts! Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC

Jeyakumar from India No COI #Nephjc

The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...

#nephjc Jeyakumar from India I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review

Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR? www.nephjc.com/news/2025/10...

📢 The 2025 ACC/AHA Hypertension Guideline Update is here. Join the discussion on #Bluesky tonight (9/16, 9 pm EST). We’ll unpack key changes, clinical implications, and what it means for your practice. 🫀🫘🧠 #Nephjc

ISPD APCN Malaysia 2025 . Talk on fungal peritonitis in CAPD

🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky @brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts *the original article from @asnpublications.bsky.social www.nephjc.com/news/nephjc-...

another great quote in that chapter "Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also, "And I don't deserve it, so I don't need to worry about it happening to me." Stop blaming people for having a disease #NephJC"

#nephjc Jeyakumar Meyyappan from India “Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “

“Where are the drugs? The drugs are where the disease is not. And where is the disease? The disease is where the drugs are not.” A powerful book! Looking forward to tomorrow’s book club!

Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC

😎Check out the VA for HiLO by @sejalplakhani.bsky.social 🆒 This should be quite the discussion, don't miss it! #NephJC #NephSky www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract

HiLo, HiLo it's off to work we go! ⛏️ Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️ www.nephjc.com/news/hilo-tr...

Severe AKI in the ICU: Management ca. 2025 #Nephpearls #AKIinICU #NephSky 👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/

#nephjc Hello all , Jeyakumar from India . I stick to creatinine for most decisions. Would love to know about the gap though

My approach with the #nsmra when egfr less than 45-50 ie #flozin first. If egfr over 45 start both at the same time because #YOLO #Nephjc

#NephJC Hello all. This is Jeyakumar from Lucknow. No COI

With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?' #NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social #MedSky www.nephjc.com/news/confide...

Check out the blog summary . CONFIDENCE How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ? www.nephjc.com/news/confide...

Check out the latest KDIGO Direct: kdigo.co/KDIGO-Direct... In this issue: 📗 Nephrotic Syndrome in Children GL publishes 📢 Dr. Wanner elected KDIGO Co-Chair 💔 KDIGO mourns Dr. Rinaldo Bellomo 🌍 KDIGO convenes Green Dialysis Conference 🏛️ KDIGO at #ERA25 🎥 New resources on #ADPKD, #C3G, #CKM & #IgAN

👋Want to get my attention...start bleeding 🩸 Hey #NephSky #NephJC fans! Check out the VA on ddAVP and kidney biopsy bleeding for tonite's discussion on #bluesky at 9pm by Dr. Divya Bajpai www.nephjc.com/news/2025/5/13/desmopressin-for-kidney-biopsy-the-visual-abstract